½ÃÀ庸°í¼­
»óǰÄÚµå
1600150

¼¼°èÀÇ ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : Á¦Ç°, ±â¼ú, Á¶ÀÛ ¸ðµå, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Membrane Chromatography Market by Product, Technique, Operation Mode, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀº 2023³â¿¡ 3¾ï 8,469¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 4¾ï 2,445¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.42%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7¾ï 7,037¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ´Â ¾×ü Å©·Î¸¶Åä±×·¡ÇÇÀÇ ¼±Åüº°ú ¿©°úÀÇ ³ôÀº ó¸® ´É·ÂÀ» ÅëÇÕÇÑ »ýüºÐÀÚÀÇ ºÐ¸®¿Í Á¤Á¦¿¡ »ç¿ëµÇ´Â »ý¸í°øÇп¡¼­ ¸Å¿ì Áß¿äÇÑ ±â¼úÀÔ´Ï´Ù. ´Ü¹éÁú »ý»êÀ» À§ÇÑ È¿À²ÀûÀ̰í È®Àå °¡´ÉÇÑ Á¤Á¦ ¹æ¹ýÀÌ ÇÊ¿äÇÑ ¹ÙÀÌ¿ÀÀǾàǰ °øÁ¤¿¡¼­ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ ±âÀÎ ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â ÁÖ·Î Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ¿¬±¸ ¹× Çмú±â°ü, ¿¬±¸¡¤Á¦Á¶ ¼öʱâ°üÀÔ´Ï´Ù. Ä¡·á¹ýÀÇ ¿¬±¸ °³¹ß ÅõÀÚ Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. Áõ°¡ ¹× Ä¡·á °³¹ß¿¡¼­ ¸ÂÃãÇü Á¤Á¦ ±â¼ú Á¦°ø, ¹ÙÀÌ¿À ½Ã¹Ð·¯ ¹× »ý¹° Á¦Á¦ÀÇ ÀαⰡ Áõ°¡ÇÔ¿¡ µû¶ó ±âȸ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ »óȲ°ú °°Àº ¹®Á¦°¡ ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú°ú °°Àº ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½Ã½ºÅÛÀÇ ¹ü¿ë¼º°ú °ß°í¼ºÀ» ³ôÀÌ´Â ±â¼ú Çõ½Å¿¡ ÅõÀÚÇÏ´Â °ÍÀÌ ÁÁ½À´Ï´Ù. Á¦¾à ȸ»ç¿ÍÀÇ Çù¾÷À» ¸ð»öÇÏ¸é Æ¯Á¤ °í°´ÀÇ ¿ä±¸¿¡ ºÎÀÀÇÏ´Â ¸ÂÃãÇü ¼Ö·ç¼ÇÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. »ý¸í°øÇÐ ÀÎÇÁ¶ó°¡ ¼ºÀåÇϰí ÀÖ´Â ½ÅÈï ½ÃÀåÀ» ´ë»óÀ¸·Î ÇÏ´Â °ÍÀº ½ÇÇà°¡´ÉÇÑ ÁøÀÔÁ¡À» Á¦°øÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» °³¹ßÇϰí ÀüÅëÀûÀÎ ÇÁ·¹ÀÓ ¿öÅ©¿¡ Àû¿ëµÇÁö ¾Ê´Â ¾ÖÇø®ÄÉÀ̼ÇÀ» È®Àå ÇÒ ¼öÀÖ´Â ±âȸ¸¦ º¸¿©ÁÝ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 3¾ï 8,469¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 4¾ï 2,445¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 7¾ï 7,037¸¸ ´Þ·¯
CAGR(%) 10.42%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¹ÙÀÌ¿ÀÀǾàǰ ¼ö¿ä Áõ°¡
    • ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ±â¼úÀÇ ±â¼úÀû Áøº¸
    • ¾çÈ£ÇÑ ±ÔÁ¦ ȯ°æ°ú ¹ÙÀÌ¿À ÀǾàǰ Àΰ¡ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ãʱâ ÅõÀÚºñ¿ë ³ôÀÌ
  • ½ÃÀå ±âȸ
    • ¹ÙÀÌ¿ÀÀǾàǰ»ê¾÷¿¡ À־ÀÇ ¿¬¼Ó ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º·ÎÀÇ ½ÃÇÁÆ® Áõ°¡
    • ÀÏȸ¿ë ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¹ß
  • ½ÃÀåÀÇ °úÁ¦
    • ±âÁ¸ ½Ã½ºÅÛ°úÀÇ È£È¯¼º°ú ÅëÇÕ ¹®Á¦

Porter's Five Force : ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ¼³¸íÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÏ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå¿¡¼­ °æÀï ±¸µµ¸¦ ÆÄ¾Ç

¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ¼¼ºÐÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ °ÝÈ­µÇ´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡ µû¶ó °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ¸¶·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¹ÙÀÌ¿ÀÀǾàǰ ¼ö¿ä Áõ°¡
      • ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ±â¼úÀÇ ±â¼úÀû Áøº¸
      • ¹Ù¶÷Á÷ÇÑ ±ÔÁ¦È¯°æ°ú ¹ÙÀÌ¿ÀÀǾàǰ ½ÂÀÎ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • Ãʱâ ÅõÀÚ ºñ¿ëÀÌ ³ô´Ù
    • ±âȸ
      • ¹ÙÀÌ¿À ÀǾàǰ »ê¾÷¿¡¼­ ¿¬¼Ó ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º·ÎÀÇ Àüȯ Áõ°¡
      • ÀÏȸ¿ë ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¹ß
    • °úÁ¦
      • ±âÁ¸ ½Ã½ºÅÛ°úÀÇ È£È¯¼º°ú ÅëÇÕ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : ´Ù¾çÇÑ ¿¬±¸¼ÒÀÇ ¿ä±¸¿¡ ´ëÀÀÇϴ Ȧ´õ¿¡¼­ ÁÖ»ç±â ÇÊÅͱîÁö, È¿À²ÀûÀÎ ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ¿¡ ÇʼöÀûÀÎ ºÎ¼Óǰ
    • ÃÖÁ¾ »ç¿ëÀÚ: ¿¬±¸ ±â°ü ¹× Á¦¾à ȸ»ç¸¦ À§ÇÑ Çõ½Å¼º, È¿À²¼º, ÄÄÇöóÀ̾𽺠º¸Àå, È®À强, ÀûÀÀ¼º, »ç¿ëÀÚ Ä£È­ÀûÀÎ ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ¼Ö·ç¼Ç
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : Á¦Ç°º°

  • ¼Ò°³
  • ºÎ¼Óǰ
  • ¼Ò¸ðǰ
    • ĸ½¶, Ä«¼¼Æ®, īƮ¸®Áö
    • ÇÊÅÍ Ç÷¹ÀÌÆ®
    • ¸âºê·¹ÀÎ µð½ºÅ© ¹× ½ÃÆ®
    • ½ºÇÉ Ä®·³
    • ÁÖ»ç±â ÇÊÅÍ

Á¦7Àå ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : ±â¼úº°

  • ¼Ò°³
  • ģȭ¼º ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ
  • ¼Ò¼ö¼º »óÈ£ÀÛ¿ë ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ
  • À̿ ±³È¯¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ
    • À½À̿ ±³È¯¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ
    • ¾çÀ̿ ±³È¯¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ

Á¦8Àå ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : Á¶ÀÛ ¸ðµåº°

  • ¼Ò°³
  • Bind-Elute ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ
  • Flow-Through ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ

Á¦9Àå ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • °è¾à¿¬±¸Çмú¿¬±¸±â°ü
  • Á¶Á÷
  • Á¦¾à¡¤¹ÙÀÌ¿À ÀǾàǰ ±â¾÷

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸âºê·¹ÀÎ Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Shimadzu, ARC¿ÍÀÇ Á¦ÈÞ¸¦ È®´ëÇØ, °¡½º Å©·Î¸¶Åä±×·¡ÇÇ¿¡ À־ÀÇ ¼±ÁøÀûÀÎ °ËÃ⠽ýºÅÛÀ» ÅëÇÕ
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • Asahi Kasei Corporation
  • Cole-Parmer Instrument Company, LLC
  • Corning Life Sciences
  • Danaher Corporation
  • DuPont de Nemours, Inc.
  • GL Sciences Inc.
  • GVS SpA
  • Membrane Solutions LLC
  • Merck KGaA
  • Purilogics, LLC by Donaldson Company, Inc.
  • Regis Technologies, Inc.
  • Restek Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
JHS 24.12.09

The Membrane Chromatography Market was valued at USD 384.69 million in 2023, expected to reach USD 424.45 million in 2024, and is projected to grow at a CAGR of 10.42%, to USD 770.37 million by 2030.

Membrane chromatography is a pivotal technique in biotechnology used for biomolecule separation and purification, integrating the selectivity of liquid chromatography with the high throughput of filtration. Its necessity stems from growing demands in biopharmaceutical processing, where there's a need for efficient and scalable purification methods to produce monoclonal antibodies and recombinant proteins. The end-use scope primarily encompasses pharmaceutical and biotechnology firms, research and academic institutions, and contract research and manufacturing organizations. Key growth influencers include advancements in biopharmaceutical production, increased adoption of single-use technologies, and rising investments in R&D for novel therapies. The push towards efficient downstream processes and cost reductions also fuels this market. Opportunities expand with the increased focus on precision medicine, offering tailored purification techniques in therapeutic development, and the rising popularity of biosimilars and biologic products. However, challenges like high initial costs, competition from traditional chromatography techniques, and the complex regulatory landscape can hinder growth. Market players are recommended to invest in innovations that enhance the versatility and robustness of membrane chromatography systems, such as hybrid or multi-modal techniques offering improved binding capacities and processing speeds. The integration of automation and digitization for real-time processing analytics could also be essential. Furthermore, exploring collaborations with biopharma firms could lead to customized solutions catering to specific client needs. Targeting emerging markets with growing biotechnology infrastructure might offer viable entry points. The market, driven by persistent innovation and demand for efficiency, is dynamic, showcasing opportunities in developing enhanced systems and expanding applications outside traditional boundaries. As such, research focusing on sustainability and cost-effectiveness of membrane chromatography processes is crucial for businesses aiming to capitalize on this burgeoning sector.

KEY MARKET STATISTICS
Base Year [2023] USD 384.69 million
Estimated Year [2024] USD 424.45 million
Forecast Year [2030] USD 770.37 million
CAGR (%) 10.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Membrane Chromatography Market

The Membrane Chromatography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for biopharmaceuticals
    • Technological advancements in membrane chromatography technologies
    • Favorable regulatory environments and increased approvals for biopharmaceutical products
  • Market Restraints
    • High initial investment cost
  • Market Opportunities
    • Increasing shift towards continuous bioprocessing in the biopharmaceutical industry
    • Ongoing development of single-use technologies
  • Market Challenges
    • Compatibility and integration issues with existing systems

Porter's Five Forces: A Strategic Tool for Navigating the Membrane Chromatography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Membrane Chromatography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Membrane Chromatography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Membrane Chromatography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Membrane Chromatography Market

A detailed market share analysis in the Membrane Chromatography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Membrane Chromatography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Membrane Chromatography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Membrane Chromatography Market

A strategic analysis of the Membrane Chromatography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Membrane Chromatography Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Asahi Kasei Corporation, Cole-Parmer Instrument Company, LLC, Corning Life Sciences, Danaher Corporation, DuPont de Nemours, Inc., GL Sciences Inc., GVS S.p.A., Membrane Solutions LLC, Merck KGaA, Purilogics, LLC by Donaldson Company, Inc., Regis Technologies, Inc., Restek Corporation, Sartorius AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Membrane Chromatography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories and Consumables. The Consumables is further studied across Capsules, Cassettes, & Cartridges, Filter Plates, Membrane Discs & Sheets, Spin Columns, and Syringe Filters.
  • Based on Technique, market is studied across Affinity Membrane Chromatography, Hydrophobic Interaction Membrane Chromatography, and Ion Exchange Membrane Chromatography. The Ion Exchange Membrane Chromatography is further studied across Anion Exchange Membrane Chromatography and Cation Exchange Membrane Chromatography.
  • Based on Operation Mode, market is studied across Bind-Elute Membrane Chromatography and Flow-Through Membrane Chromatography.
  • Based on End-User, market is studied across Contract ResearchAcademic & Research Institutes, Organizations, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biopharmaceuticals
      • 5.1.1.2. Technological advancements in membrane chromatography technologies
      • 5.1.1.3. Favorable regulatory environments and increased approvals for biopharmaceutical products
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investment cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing shift towards continuous bioprocessing in the biopharmaceutical industry
      • 5.1.3.2. Ongoing development of single-use technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Compatibility and integration issues with existing systems
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Essential accessories for efficient membrane chromatography, from holders to syringe filters for diverse laboratory needs
    • 5.2.2. End User: Scalable, adaptive, and user-friendly membrane chromatography solutions for research institutes, and pharmaceutical companies, ensuring innovation, efficiency, and compliance
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Membrane Chromatography Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Consumables
    • 6.3.1. Capsules, Cassettes, & Cartridges
    • 6.3.2. Filter Plates
    • 6.3.3. Membrane Discs & Sheets
    • 6.3.4. Spin Columns
    • 6.3.5. Syringe Filters

7. Membrane Chromatography Market, by Technique

  • 7.1. Introduction
  • 7.2. Affinity Membrane Chromatography
  • 7.3. Hydrophobic Interaction Membrane Chromatography
  • 7.4. Ion Exchange Membrane Chromatography
    • 7.4.1. Anion Exchange Membrane Chromatography
    • 7.4.2. Cation Exchange Membrane Chromatography

8. Membrane Chromatography Market, by Operation Mode

  • 8.1. Introduction
  • 8.2. Bind-Elute Membrane Chromatography
  • 8.3. Flow-Through Membrane Chromatography

9. Membrane Chromatography Market, by End-User

  • 9.1. Introduction
  • 9.2. Contract ResearchAcademic & Research Institutes
  • 9.3. Organizations
  • 9.4. Pharmaceutical & Biopharmaceutical Companies

10. Americas Membrane Chromatography Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Membrane Chromatography Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Membrane Chromatography Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Shimadzu Expands Partnership with ARC to Integrate Advanced Detection Systems in Gas Chromatography
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Asahi Kasei Corporation
  • 3. Cole-Parmer Instrument Company, LLC
  • 4. Corning Life Sciences
  • 5. Danaher Corporation
  • 6. DuPont de Nemours, Inc.
  • 7. GL Sciences Inc.
  • 8. GVS S.p.A.
  • 9. Membrane Solutions LLC
  • 10. Merck KGaA
  • 11. Purilogics, LLC by Donaldson Company, Inc.
  • 12. Regis Technologies, Inc.
  • 13. Restek Corporation
  • 14. Sartorius AG
  • 15. Thermo Fisher Scientific, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦